{"id":"W2343845238","doi":"10.1200/jco.2012.30.5_suppl.286","title":"A phase I trial of intravesical antisense oligonucleotide targeting heat shock protein 27 (OGX-427) for the treatment of non-muscle-invasive bladder cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Tolerability; Urology; Internal medicine; Progressive disease; Adverse effect; Cancer; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007822608,0.001131618,0.001077375,0.0003127756,0.0003500556,0.0007887347,0.0006946328,0.001403752,0.003666585],"category_scores_gemma":[0.0004091848,0.0004606974,0.000738815,0.0002343203,0.0006803806,0.0005577817,0.0002231226,0.002621637,0.0008372233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005438746,"about_ca_system_score_gemma":0.001405941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007943836,"about_ca_topic_score_gemma":0.001939186,"domain_scores_codex":[0.9997709,0.00008287932,0.00000992552,0.00004477584,0.00002481497,0.00006672362],"domain_scores_gemma":[0.999631,0.00005079472,0.00006158829,0.0000276501,0.00002528576,0.0002036751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7040999,0.09669751,0.003248367,0.001124675,0.0007212584,0.0003301804,0.0003434591,0.002237173,0.1004761,0.0005591152,0.004751375,0.08541095],"study_design_scores_gemma":[0.4861646,0.4971799,0.004232597,0.00003166267,0.0002213004,0.0002046957,0.0000472133,0.0009774971,0.007915083,0.0002061724,0.002798529,0.00002089564],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898942,0.001566728,0.0006460056,0.0005073548,0.0001888764,0.003685247,0.0009628994,0.0001135117,0.002435116],"genre_scores_gemma":[0.9829504,0.001695668,0.001759097,0.00121809,0.0001569223,0.004011638,0.002336228,0.00002843543,0.005843441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003666585,"threshold_uncertainty_score":0.01226592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09718729656403201,"score_gpt":0.4771249404635241,"score_spread":0.3799376438994921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}